4//SEC Filing
Smith Mark Douglas 4
Accession 0001765581-23-000110
CIK 0001232524other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:39 PM ET
Size
4.7 KB
Accession
0001765581-23-000110
Insider Transaction Report
Form 4
Smith Mark Douglas
Director
Transactions
- Sale
Ordinary Shares
2023-12-04$119.27/sh−417$49,736→ 6,888 total
Footnotes (1)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001756253
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:39 PM ET
- Size
- 4.7 KB